ID

23795

Description

A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1); ODM derived from: https://clinicaltrials.gov/show/NCT00500682

Lien

https://clinicaltrials.gov/show/NCT00500682

Mots-clés

Versions (1)
  1. 13/07/2017 13/07/2017 -
Téléchargé le

13 juillet 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Chronic Kidney Disease NCT00500682

Anglais

Eligibility Chronic Kidney Disease NCT00500682

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 18 years or older
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
moderate to severe ckd, not anticipated to require dialysis or renal transplant within the next 6 months
Description

Chronic Kidney Disease Moderate | Chronic Kidney Disease Severe | Dialysis Unexpected | Kidney Transplantation Unexpected

Type de données

boolean

Alias
UMLS CUI [1,1]
C1561643
UMLS CUI [1,2]
C0205081
UMLS CUI [2,1]
C1561643
UMLS CUI [2,2]
C0205082
UMLS CUI [3,1]
C0011946
UMLS CUI [3,2]
C4055646
UMLS CUI [4,1]
C0022671
UMLS CUI [4,2]
C4055646
patient survival expected to be no less than one year
Description

Life Expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
serum creatinine in men >= 2.0 mg/dl (>= 177 µmol/l) and <= 5.0 mg/dl (<= 442
Description

Creatinine measurement, serum | Gender

Type de données

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C0079399
µmol/l), and in women >= 1.5 mg/dl (>= 133 µmol/l) and <= 5.0 mg/dl (<= 442 µmol/l) at screening
Description

Creatinine measurement, serum | Gender | Screening

Type de données

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C0079399
UMLS CUI [3]
C0220908
urinary total protein to urinary total creatinine ratio must be >= 0.5 on a spot void at screening
Description

Urine protein/creatinine ratio measurement

Type de données

boolean

Alias
UMLS CUI [1]
C1096054
blood pressure <= 160/90 mmhg at both screening and baseline. in addition, blood pressure, if measured, must have been stable in hypertensive patients over the 3 months prior to screening, with no more than 1 blood pressure reading > 160/90 mmhg
Description

Blood pressure | Patient Hypertensive Stable blood pressure

Type de données

boolean

Alias
UMLS CUI [1]
C1271104
UMLS CUI [2,1]
C0030705
UMLS CUI [2,2]
C0857121
UMLS CUI [2,3]
C0428896
in patients being treated for hypertension, they should be on a stable anti-hypertensive regimen
Description

Therapeutic procedure Hypertensive disease | Antihypertensive therapy Stable

Type de données

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0020538
UMLS CUI [2,1]
C0585941
UMLS CUI [2,2]
C0205360
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
obstructive or reversible cause of kidney disease
Description

Kidney Disease Obstructive | Kidney Disease Cause Reversible

Type de données

boolean

Alias
UMLS CUI [1,1]
C0022658
UMLS CUI [1,2]
C0549186
UMLS CUI [2,1]
C0022658
UMLS CUI [2,2]
C0015127
UMLS CUI [2,3]
C0205343
nephrotic syndrome defined as a ratio of urinary total protein to urinary creatinine of > 6.0 as measured on a spot void
Description

Nephrotic Syndrome | Urine protein/creatinine ratio measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0027726
UMLS CUI [2]
C1096054
adult polycystic kidney disease
Description

Polycystic Kidney Disease Adult

Type de données

boolean

Alias
UMLS CUI [1,1]
C0022680
UMLS CUI [1,2]
C0001675
history of previous kidney transplant
Description

Kidney Transplantation

Type de données

boolean

Alias
UMLS CUI [1]
C0022671
history of recent (within the past 6 months) accelerated or malignant hypertension
Description

Malignant Hypertension

Type de données

boolean

Alias
UMLS CUI [1]
C0020540
uncontrolled arrhythmia or severe cardiac disease within the past 6 months
Description

Cardiac Arrhythmia Uncontrolled | Heart Disease Severe

Type de données

boolean

Alias
UMLS CUI [1,1]
C0003811
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0018799
UMLS CUI [2,2]
C0205082
history of malabsorption, inflammatory bowel disease, hiatal hernia, active peptic ulcer, or severe gi dysmotility, not attributable to the use of a phosphate binder
Description

Malabsorption | Inflammatory Bowel Diseases | Hiatal Hernia | Peptic Ulcer | Gastrointestinal dysmotility Severe | Phosphate Binder Etiology aspects Absent

Type de données

boolean

Alias
UMLS CUI [1]
C3714745
UMLS CUI [2]
C0021390
UMLS CUI [3]
C3489393
UMLS CUI [4]
C0030920
UMLS CUI [5,1]
C1836923
UMLS CUI [5,2]
C0205082
UMLS CUI [6,1]
C2267031
UMLS CUI [6,2]
C0015127
UMLS CUI [6,3]
C0332197
received any investigational agent or participated in a clinical study within the previous 3 months
Description

Investigational New Drugs | Study Subject Participation Status

Type de données

boolean

Alias
UMLS CUI [1]
C0013230
UMLS CUI [2]
C2348568
presence of any significant medical condition that might create an undue risk with study participation, or significantly confound the collection of safety and efficacy data in this study
Description

Medical condition At risk Study Subject Participation Status | Medical condition Interferes with Safety Study data | Medical condition Interferes with Effectiveness Study data

Type de données

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C1444641
UMLS CUI [1,3]
C2348568
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0036043
UMLS CUI [2,4]
C0681873
UMLS CUI [3,1]
C3843040
UMLS CUI [3,2]
C0521102
UMLS CUI [3,3]
C1280519
UMLS CUI [3,4]
C0681873
Retour au début de la page

Similar models

Eligibility Chronic Kidney Disease NCT00500682

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age 18 years or older
boolean
C0001779 (UMLS CUI [1])
Chronic Kidney Disease Moderate | Chronic Kidney Disease Severe | Dialysis Unexpected | Kidney Transplantation Unexpected
Item
moderate to severe ckd, not anticipated to require dialysis or renal transplant within the next 6 months
boolean
C1561643 (UMLS CUI [1,1])
C0205081 (UMLS CUI [1,2])
C1561643 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0011946 (UMLS CUI [3,1])
C4055646 (UMLS CUI [3,2])
C0022671 (UMLS CUI [4,1])
C4055646 (UMLS CUI [4,2])
Life Expectancy
Item
patient survival expected to be no less than one year
boolean
C0023671 (UMLS CUI [1])
Creatinine measurement, serum | Gender
Item
serum creatinine in men >= 2.0 mg/dl (>= 177 µmol/l) and <= 5.0 mg/dl (<= 442
boolean
C0201976 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
Creatinine measurement, serum | Gender | Screening
Item
µmol/l), and in women >= 1.5 mg/dl (>= 133 µmol/l) and <= 5.0 mg/dl (<= 442 µmol/l) at screening
boolean
C0201976 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
C0220908 (UMLS CUI [3])
Urine protein/creatinine ratio measurement
Item
urinary total protein to urinary total creatinine ratio must be >= 0.5 on a spot void at screening
boolean
C1096054 (UMLS CUI [1])
Blood pressure | Patient Hypertensive Stable blood pressure
Item
blood pressure <= 160/90 mmhg at both screening and baseline. in addition, blood pressure, if measured, must have been stable in hypertensive patients over the 3 months prior to screening, with no more than 1 blood pressure reading > 160/90 mmhg
boolean
C1271104 (UMLS CUI [1])
C0030705 (UMLS CUI [2,1])
C0857121 (UMLS CUI [2,2])
C0428896 (UMLS CUI [2,3])
Therapeutic procedure Hypertensive disease | Antihypertensive therapy Stable
Item
in patients being treated for hypertension, they should be on a stable anti-hypertensive regimen
boolean
C0087111 (UMLS CUI [1,1])
C0020538 (UMLS CUI [1,2])
C0585941 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Kidney Disease Obstructive | Kidney Disease Cause Reversible
Item
obstructive or reversible cause of kidney disease
boolean
C0022658 (UMLS CUI [1,1])
C0549186 (UMLS CUI [1,2])
C0022658 (UMLS CUI [2,1])
C0015127 (UMLS CUI [2,2])
C0205343 (UMLS CUI [2,3])
Nephrotic Syndrome | Urine protein/creatinine ratio measurement
Item
nephrotic syndrome defined as a ratio of urinary total protein to urinary creatinine of > 6.0 as measured on a spot void
boolean
C0027726 (UMLS CUI [1])
C1096054 (UMLS CUI [2])
Polycystic Kidney Disease Adult
Item
adult polycystic kidney disease
boolean
C0022680 (UMLS CUI [1,1])
C0001675 (UMLS CUI [1,2])
Kidney Transplantation
Item
history of previous kidney transplant
boolean
C0022671 (UMLS CUI [1])
Malignant Hypertension
Item
history of recent (within the past 6 months) accelerated or malignant hypertension
boolean
C0020540 (UMLS CUI [1])
Cardiac Arrhythmia Uncontrolled | Heart Disease Severe
Item
uncontrolled arrhythmia or severe cardiac disease within the past 6 months
boolean
C0003811 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0018799 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
Malabsorption | Inflammatory Bowel Diseases | Hiatal Hernia | Peptic Ulcer | Gastrointestinal dysmotility Severe | Phosphate Binder Etiology aspects Absent
Item
history of malabsorption, inflammatory bowel disease, hiatal hernia, active peptic ulcer, or severe gi dysmotility, not attributable to the use of a phosphate binder
boolean
C3714745 (UMLS CUI [1])
C0021390 (UMLS CUI [2])
C3489393 (UMLS CUI [3])
C0030920 (UMLS CUI [4])
C1836923 (UMLS CUI [5,1])
C0205082 (UMLS CUI [5,2])
C2267031 (UMLS CUI [6,1])
C0015127 (UMLS CUI [6,2])
C0332197 (UMLS CUI [6,3])
Investigational New Drugs | Study Subject Participation Status
Item
received any investigational agent or participated in a clinical study within the previous 3 months
boolean
C0013230 (UMLS CUI [1])
C2348568 (UMLS CUI [2])
Medical condition At risk Study Subject Participation Status | Medical condition Interferes with Safety Study data | Medical condition Interferes with Effectiveness Study data
Item
presence of any significant medical condition that might create an undue risk with study participation, or significantly confound the collection of safety and efficacy data in this study
boolean
C3843040 (UMLS CUI [1,1])
C1444641 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C3843040 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0036043 (UMLS CUI [2,3])
C0681873 (UMLS CUI [2,4])
C3843040 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C1280519 (UMLS CUI [3,3])
C0681873 (UMLS CUI [3,4])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial